Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Icad Inc (NQ: ICAD )

17.17 USD -0.62 (-3.49%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 94,211
Open 17.70
Bid (Size) 17.01 (1)
Ask (Size) 19.70 (5)
Prev. Close 17.79
Today's Range 17.03 - 17.85
52wk Range 8.320 - 21.44
Shares Outstanding 24,983,491
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
iCAD’s ProFound AI for Digital Breast Tomosynthesis Version 3.0 Receives CE Mark Approval
iCAD’s third generation artificial intelligence solution for 3D mammography offers considerable improvement in algorithm specificity performance and faster processing compared to previous generations 
From GlobeNewswire News Releases
iCAD Signs Global Distribution Agreement with Sectra
Agreement will expand access to ProFound AI and ProFound AI Risk to more facilities and imaging centers worldwide 
From GlobeNewswire News Releases

Performance

YTD
+29.00%
+29.00%
1 Month
+2.94%
+2.94%
3 Month
-11.27%
-11.27%
6 Month
+24.96%
+24.96%
1 Year
+65.89%
+65.89%

More News

Read More
iCAD to Participate in Upcoming Virtual Investor Conferences
From GlobeNewswire News Releases
iCAD Announces Educational Webinar Featuring Leading Global Experts Discussing New Multidisciplinary Approach for Treating Brain Tumors, May 25
From GlobeNewswire News Releases
iCAD Reports Financial Results for First Quarter Ended March 31, 2021
From GlobeNewswire News Releases
iCAD to Report First Quarter 2021 Financial Results on Wednesday, April 28
From GlobeNewswire News Releases
New Research Confirms iCAD’s ProFound AI Aids Breast Cancer Detection with Digital Breast Tomosynthesis, Improves Radiologists’ Workflow
From GlobeNewswire News Releases
iCAD Announces Estimated Q1 Revenues and Upcoming CFO Transition
From GlobeNewswire News Releases
New Research Indicates ProFound AI May Reduce Interval Breast Cancer Rates
From GlobeNewswire News Releases
iCAD Announces FDA Clearance for ProFound AI Version 3.0 for 3D Mammography
From GlobeNewswire News Releases
New Research Supporting ProFound AI Presented at European Congress of Radiology Online Meeting
From GlobeNewswire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.